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Abstract: Although assisted reproduction technologies (ARTs) are recognised as safe, and most
of the offspring seem apparently healthy, there is clear evidence that ARTs are associated with
changes in the embryo’s developmental trajectory, which incur physiological consequences during the
prenatal and postnatal stages of life. The present study aimed to address the influence of early (day-3
embryos) embryo transfer and cryopreservation on embryo survival, size, and metabolome at the
preimplantation stage (day-6 embryos). To this end, fresh-transferred (FT) and vitrified-transferred
(VT) embryos were compared using naturally-conceived (NC) embryos as a control reference. The
results show that as in vitro manipulation was increased (NC < FT < VT), both embryo survival
rate (0.91 ± 0.02, 0.78 ± 0.05 and 0.63 ± 0.05, for NC, FT, and VT groups, respectively) and embryo
size (3.21 ± 0.49 mm, 2.15 ± 0.51 mm, 1.76 ± 0.46 mm of diameter for NC, FT, and VT groups,
respectively) were significantly decreased. Moreover, an unbiased metabolomics analysis showed
overall down-accumulation in 40 metabolites among the three experimental groups, with embryo
transfer and embryo cryopreservation procedures both exerting a cumulative effect. In this regard,
targeted metabolomics findings revealed a significant reduction in some metabolites involved in
metabolic pathways, such as the Krebs cycle, amino acids, unsaturated fatty acids, and arachidonic
acid metabolisms. Altogether, these findings highlight a synergistic effect between the embryo transfer
and vitrification procedures in preimplantation embryos. However, the ex vivo manipulation during
embryo transfer seemed to be the major trigger of the embryonic changes, as the deviations added by
the vitrification process were relatively smaller.
Keywords: embryo manipulation; cryopreservation; stress; metabolism; developmental plasticity;
developmental programming
1. Introduction
During early embryonic development, the maternal environment supports optimal embryogenesis,
providing stage-specific nutrients, growth factors, hormones, antioxidants, and other regulatory
molecules that are required by the embryo’s evolving developmental and metabolic requirements [1–4].
Mounting evidence suggests that early exposures to stressful situations that affect these elegantly
orchestrated milestones may influence developmental trajectories in the short and long term [5,6].
Under these suboptimal situations, the embryo’s developmental plasticity is adept at compensating
this environmental drawback if the stress is within the normal range [7]. This mechanism may
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facilitate the setting of suitable growth and metabolic parameters to match the perceived environment
but, if environmental conditions change later, developed adaptations may become maladaptive [5].
Besides, extreme exposures outside the normal range are associated with abnormal widespread
epigenetic remodelling, which can persist through subsequent cell cycles and drive an altered
developmental programme [5–7]. Illuminating pieces of evidence come from the fields applying
Assisted Reproductive Technologies (ARTs), which expose gametes and the early embryo to precisely
timed in vitro manipulations in static culture mediums, under some physical and chemical stressors,
and deprived of the maternal interface [4,8]. Thus, being conscious of the limitations when recapitulating
the in vivo dynamism, and although the majority of ART-offspring show healthy development,
safety concerns regarding ARTs are today a matter of debate [9]. Extensive reviews have reported that
ART-stressors during in vitro fertilisation (IVF) and in vitro culture (IVC) may not only impair embryo
development in the laboratory, but can also have downstream effects after the embryo transfer across
gestation and after birth [7,10–13]. One potential strategy to attenuate the suboptimal conditions is the
use of oviductal and uterine secretions and/or cells, which results in embryos closer to those conceived
naturally [14–17]. As the increasing use of ARTs continues to spread worldwide, mimicking in vivo
conditions is especially important to guarantee the safety of ART procedures, but some of them are
extremely contradictory with this concept, such as embryo cryopreservation.
Regardless of the cryopreservation method used, all of them require embryos to be exposed to an
environment in which they have no intrinsic ability to survive (i.e., toxic cryoprotectant solutions and
ultra-low temperatures [18]). The study of the embryo cryopreservation legacy in the developmental
trajectory in utero and throughout life has merited our attention for decades. In this sense, we proved
that embryo cryopreservation disturbs preimplantation embryo gene expression, increases foetal
losses and placental remodelling, modifies both prenatal and postnatal growth trajectories, and incurs
phenotypic changes in adulthood [19–26]. However, during a vitrified embryo transfer procedure,
embryos must necessarily be recovered, catalogued, vitrified, warmed, and transferred, so the role of
individual stressors has not currently been differentiated, and all of them are considered together as part
of the whole process. Particularly, Garcia-Dominguez et al. [26] have shown that both embryo transfer
and embryo vitrification procedures are important triggers of long-term developmental reshaping.
Therefore, the importance of each stressor and its interactions (additive, antagonistic or synergistic
effects) during an ART-cycle in the embryo trajectory should not be underestimated. In this scenario,
the aim of this study was to address the influence of in vitro manipulation during fresh and vitrified
embryo transfer procedures on the preimplantation embryo development and metabolome.
2. Results
2.1. In Vivo Embryo Development
Data showed that the survival rate decreased as embryonic manipulation increased, noting lower
values for vitrified-transferred (VT) embryos (0.63 ± 0.05) than for fresh-transferred (FT) embryos
(0.78 ± 0.05; p = 0.042). Both VT and FT presented lower survival rates than naturally-conceived
(NC) embryos (0.91 ± 0.02; p = 0.000 and p = 0.017 for NC vs. VT and NC vs. FT comparison,
respectively). The foster mother effect was not significant and the estimate effect was 0.29 ± 0.25;
p = 0.0239. The morphometric details of day-6 in vivo developed embryos were noted in Table 1,
showing that embryos were also smaller as in vitro manipulation increased. Then VT embryos
presented a lower diameter area and perimeter than FT embryos, whose size was lower compared to
the NC group.
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Table 1. Morphometric analysis of 6-day-old embryos after in vivo development by natural conception
or following fresh or vitrified embryo transfer.
Experimental groups n Diameter (mm) Perimeter (mm) Area (mm2)
Vitrified-transferred 93 1.76 ± 0.46 c 5.81 ± 1.55 c 2.63 ± 1.34 c
Fresh-transferred 88 2.15 ± 0.51 b 7.27 ± 1.67 b 3.79 ± 1.67 b
Naturally-conceived 176 3.21 ± 0.49 a 10.67 ± 1.47 a 8.15 ± 2.39 a
p-value 0.005 0.003 0.002
Foster mother effect 7 0.04 ± 0.03 0.36 ± 0.31 0.35 ± 0.36
p-value 0.249 0.241 0.337
n: number of embryos. Data are expressed as mean ± standard error. a,b,c Values within a column with different
superscripts differ statistically.
2.2. Comparative Study of the Metabolome between In Vivo Developed Embryos
The metabolomic profiles of VT, FT, and NC in vivo developed embryos were compared in order
to unravel the effects attributable to the embryo transfer procedure (FT vs. NC), to the vitrification
procedure per se (VT vs. FT) and to the whole vitrified embryo transfer procedure (VT vs. NC). First of
all, we carried out an untargeted metabolomics analysis of both semi-polar and non-polar fractions to
gain a general overview of the metabolic changes occurring. The t-test analysis detected 40 differentially
accumulated metabolites (DAMs) for at least one of the above comparisons, however, no significant
associations were observed (false discovery rate, FDR > 0.05). Of these, 29 belonged to the semi-polar
fraction and 11 to the non-polar. Principal components analysis (PCA) biplots demonstrated clustering
among the three groups using the 87 and 27 metabolites detected in semi-polar and the non-polar
fractions, respectively (Figure 1A,B).
Focusing on the semi-polar fraction (Figure 1A), distant clusters were observed for NC and VT
embryos, the FT group being intermediate, as expected. Differences among the non-polar metabolite
profiles appeared more elusive (Figure 1B), although they seemed to follow the same trend as above,
the FT cluster being allocated between those of NC and VT. This demonstrated that deviations caused
during a vitrified embryo transfer (VT/NC) were higher than those induced after a fresh embryo
transfer (FT/NC), as vitrification procedure (VT/FT) had effects per se that were additive to the ex
vivo manipulation. Supporting this evidence, general down-accumulation was recorded after fresh
embryo transfer, vitrified embryo transfer and embryo vitrification procedure, the average fold change
being −0.62, −0.81, and −0.20 for semi-polar metabolites, and −2.64, −3.42, and −1.28 for the non-polar
ones, respectively. More specifically, Venn diagrams of the semi-polar (Figure 1C) and non-polar
(Figure 1D) DAMs showed that, although each procedure induced some condition-specific effects,
most of the DAMs that appeared after the vitrified embryo transfer can be attributed to the embryo
transfer procedure, being less attributable to the vitrification process. Particularly, of the total DAMs
noted after the vitrified embryo transfer, 46.4% (13/28) and 28.6% (8/28) of them were influenced by
the embryo transfer and embryo vitrification, respectively. Notably, 39.3% (11/28) was not directly
attributable to either procedure, suggesting that a coexistence of both triggers resulted in a synergistic
effect with long lasting metabolic alterations.
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Figure 1. Unbiased metabolomic data (untargeted study) comparing the metabolic profile of
naturally-conceived (NC) embryos and those in vivo developed after fresh embryo transfer (FT)
and vitrified embryo transfer (VT). Principal components analysis biplots of the (A) semi-polar and
(B) non-polar metabolites. Venn diagrams comparing the number of targeted (C) semi-polar and
(D) non-polar differentially accumulated metabolites after fresh embryo transfer (FT/NC), vitrified
embryo transfer (VT/NC), and embryo cryopreservation (VT/FT).
After that, a targeted analysis was performed to quantify 74 known metabolites, in a relative
way, of the primary and secondary metabolisms (Supplementary Table S1). The t-test showed
15 DAMs (p < 0.05) from which none of them had significant FDR (Table 2). Functional clustering of
the metabolites revealed alterations in metabolic pathways related to the Krebs cycle, amino acids
metabolism, unsaturated fatty acid metabolism and arachidonic acid metabolism. In concordance with
the untargeted data, general down-accumulation was recorded for all the comparisons after targeted
analysis. Altogether, metabolomics data revealed that ex vivo manipulations during the embryo
transfer technique exerted a greater impact over the preimplantation embryo metabolism than the
embryo vitrification procedure. Thus, the main differences observed after a vitrified embryo transfer
procedure seemed to be caused by the embryo transfer procedure.
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Table 2. Targeted identification of differentially accumulated metabolites in day-6 embryos after in vivo
development by natural conception or following fresh or vitrified embryo transfer. Asterisk denotes
statistical differences. FT/NC: fresh embryo transfer/naturally-conceived. VT/NC: vitrified embryo
transfer/naturally-conceived. VT/FT: vitrified embryo transfer/ fresh embryo transfer. FC: fold change.
Metabolic Pathway
Metabolite FT/NC VT/NC VT/FT
FC p-Value adj p-Value FC p-Value adj p-Value FC p-Value adj p-Value
Krebs cycle
Succinate −0.86 * 0.03 0.37 −1.13 * 0.02 0.20 −0.27 0.62 0.92
Biosynthesis of amino acids
Glutamine −0.99 * 0.05 0.37 −1.43 * 0.03 0.20 −0.43 0.60 0.92
Threonine −1.19 * 0.04 0.37 −1.10 * 0.05 0.27 0.08 0.92 0.92
Proline −0.20 0.31 0.81 −0.54 * 0.04 0.20 −0.34 0.17 0.92
Valine 0.35 0.61 0.96 1.30 * 0.03 0.20 0.95 * 0.05 0.92
Biosynthesis of unsaturated fatty acids
Adrenic acid −3.04 * 0.05 0.29 −4.90 * 0.05 0.23 −1.86 0.83 1.00
Arachidonic acid −3.00 * 0.05 0.29 −4.43 * 0.05 0.23 −1.43 0.85 1.00
Docosapentaenoic acid −2.23 * 0.05 0.29 −4.19 * 0.03 0.22 −1.96 0.67 1.00
Eicosapentaenoic acid −1.45 * 0.05 0.29 −1.99 * 0.03 0.22 −0.54 0.70 1.00
Arachidonic acid metabolism
Prostacyclin −2.47 * 0.02 0.29 −3.14 * 0.02 0.22 −0.67 0.83 1.00
19-/20-hydroxyarachidonic acid −1.83 * 0.04 0.29 −2.46 * 0.03 0.22 −0.63 0.75 1.00
11(12)oxido-5,8,14-eicosatrienoic acid −1.83 * 0.04 0.29 −2.46 * 0.03 0.22 −0.63 0.75 1.00
14(15)oxido-5,8,11-eicosatrienoic acid −1.83 * 0.04 0.29 −2.46 * 0.03 0.22 −0.63 0.75 1.00
5(6)oxido-8,11,14-eicosatrienoic acid −1.90 * 0.04 0.29 −2.46 * 0.03 0.22 −0.56 0.78 1.00
5-HETE −1.98 * 0.02 0.29 −2.95 * 0.01 0.22 −0.97 0.67 1.00
3. Discussions
Throughout this study, it has been demonstrated that more severe in vitro stress precipitated
more deviant phenotypes and metabolic alterations on preimplantation embryos. Moreover, to our
best knowledge, metabolomics was here used for the first time to address the influence of the embryo
transfer and vitrification procedures on the embryonic metabolite content. Although both techniques
are significant triggers of specific and cumulative effects, strong evidence of the negative synergy
between both stressors was provided. However, ex vivo manipulations, rather than embryo vitrification,
seemed to be largely responsible for both phenotypic and molecular deviations.
The results shown here indicate that, as embryo manipulation increased, early embryos seemed
to lose its developmental capacity within the first 3 days. Knowledge so far indicates that suboptimal
conditions during ART may induce embryonic stress responses and affect embryo viability [10,11].
In addition, cryopreservation is known for its harmful impacts on embryonic health, placing embryos at
risk from a variety of types of cryoinjury during temperature and phase transitions [18,27]. Such survival
impairment is in agreement with previous studies performed in rabbits, where manipulations of either
fresh or vitrified embryos resulted in negative developmental effects both under in vitro conditions and
in vivo [22,23,26,28–30]. It has been reported that successful hatching is dependent on a sufficiently
high number of embryonic cells, which enables blastocyst expansion and zona shedding [31]. However,
as more in vitro stress was applied, the number of total embryonic cells became more reduced [32],
embryo cryopreservation being a significant cause of cell loss [33]. This could explain both the smaller
embryo size and the lower embryo survival of VT embryos compared to those FT, the values for the
NC group being higher than for the two previous ones. To date, ART procedures have been linked
with a lower blastocyst development, slower developmental kinetics, reduced number of cells, higher
incidence of apoptosis, and great dysregulations in the epigenetic, transcriptomic, and metabolic cell
profiles [10,11]. Then, identifying the molecular changes occurring in developing embryos following
ART procedures could unveil key mechanisms to better understand why these procedures generate
embryos with altered developmental trajectories.
In the present study, 40 endogenous DAMs, globally down-accumulated, were identified among
VT, FT, and NC embryos though an unbiased (untargeted) metabolomic approach. The study of these
DAMs through PCA and Venn diagrams suggested that both the transfer technique and the vitrification
procedure induced significant modifications in the metabolic content in preimplantation embryos.
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In agreement, previously reported studies confirmed that both stressors altered gene expression
in rabbit embryos and increased the embryonic loses [22,30]. Besides, we observed that ex vivo
manipulations during the embryo transfer procedure, rather than embryo vitrification, seemed to
induce the major metabolic change following vitrified embryo transfer. The study conducted by
Salilew-Wondim et al. revealed that the shortest in vitro exposure, compared to development entirely
in vivo, induced notable changes in the embryonic epigenetic profile, the changes induced by longer
in vitro culture times being less prominent [34]. Taking these findings into account, we hypothesise
that embryonic responses are highly sensitive to the stress conditions, as disturbing optimal maternal
environment by in vitro embryo handling seems to incur higher effects compared to those induced by
apparently more stressful ARTs such as embryo cryopreservation. In addition, there are significant
elements that add to the complexity of these phenomena, as several ART-related developmental
effects could be synergic, condition-specific, strain-specific, sexually dimorphic, or may not emerge
until later into adulthood [11,13]. Here, we proved that the coexistence of two stressors (i.e., ex vivo
manipulation and vitrification) induced a synergic effect that incurred more metabolic changes than
each one individually. Details of the phenotypic variation following both fresh and vitrified embryo
transfer at adulthood were described in our recent study, detecting a cumulative effect between both
procedures [26].
To more clearly interrogate the metabolic changes associated with each stressor, we performed
a targeted analysis, identifying an overall down-accumulation in pivotal metabolites involved in the
Krebs cycle, amino acid metabolism and unsaturated fatty acid metabolism. These results were in
agreement with those found in bovine and porcine after ART at the gene expression level [35–39].
Particularly, Swain et al. showed that in vitro produced pig embryos had reduced metabolic activity,
mainly related with glycolytic pathways and the Krebs cycle, and used lesser amounts of glutamine,
compared with in vivo derived embryos at all stages [40]. Concordantly, we observed an overall
negative fold changes and low amounts of succinate and glutamine in both FT and VT embryos.
Besides, other studies in the mouse reported changes in the amino acid utilisation after in vitro embryo
production, which has been importantly linked with the embryo developmental kinetics [41,42].
Particularly, a bovine study demonstrated that fast-growing embryos consumed higher threonine
amounts than the rest [43]. Supporting this evidence, the present study revealed that both FT and VT
embryos were smaller and exhibited lower threonine content compared to the NC ones. Importantly,
some n-3 and n-6 polyunsaturated fatty acids (i.e., eicosapentaenoic acid, docosapentaenoic acid,
adrenic acid, and arachidonic acid) were also found down-accumulated in both FT and VT embryos.
These compounds mediate the regulation of genes involved in lipid and carbohydrate metabolism,
as well as the lipogenic pathways related to the fatty acid, triglycerides, and cholesterol synthesis [44].
Therefore, dysregulations of these metabolites could exert some downstream alterations that can
contribute to the metabolic and developmental changes following fresh or vitrified embryo transfer.
In particular, arachidonic acid is a precursor for the synthesis of prostaglandins, which are vital for the
embryo-maternal dialogue, for the shedding of the zona pellucida and, thereby, for the subsequent
embryo survival and development [44,45]. As some metabolites stemmed from the metabolism of
arachidonic acid were here detected down-accumulated in FT and VT embryos, it could explain its
lower survival rates compared to the NC ones. It is worth noting that some of the metabolic changes
here described have also been reported in adult tissues of ART animals [13,46–48]. Therefore, the study
of the molecular changes occurring in the preimplantation embryo after ART could provide a set of
compounds that can serve as metabolic markers to better understand and track those deviations that
appear both in the short and in the long term. In accordance with the “quiet range” of metabolic activity,
embryos with maximum developmental potential will be located in a “Goldilocks zone”, understood
as an optimal range of metabolic activity and energetic efficiency [49]. Then, following this idea,
only those embryos able to adapt their metabolism within a homeostatic range during suboptimal ART
condition could finally develop until birth. In agreement, current developmental biology has begun to
describe different ways whereby the metabolic profile of the cell and developmental programmes of
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the organism can crosstalk, establishing the notion that metabolism is not just a housekeeping process,
but instead an active effector of physiological changes [50]. In this context, the Developmental Origins
of Health and Disease (DOHaD) hypothesis evokes the idea that a wide range of conditions present in
adulthood have their origin in these embryonic adaptations [10–12]. Given the increasing numbers of
ART cycles that have been performed annually, both in humans and in animal production, monitoring
the ART legacy in both embryos and adult individuals should be mandatory and of special interest,
in order to ensure that ARTs are used in the safest possible way.
In summary, here we provide strong evidence of the metabolic reprogramming undergone by
in vivo developed preimplantational embryos following both fresh and vitrified embryo transfer.
We have demonstrated that both embryo transfer and embryo cryopreservation are significant stressors
triggering developmental reshaping, whose coexistence can induce a synergic effect causing more
deviant alterations. Additional research is required to elucidate whether the embryonic metabolic
changes against suboptimal in vitro condition can persist in the course of development and can be
used as predictors of embryo quality and adult health.
4. Materials and Methods
Unless stated otherwise, all chemicals were purchased from Sigma-Aldrich Corporation (St Louis,
MO, USA).
4.1. Animals and Ethical Statements
New Zealand rabbits belonging to the Universitat Politècnica de València were used throughout the
experiment. The animal study protocol was reviewed and approved (code: 2015/VSC/PEA/00061) by the
“Universitat Politècnica de València” ethical committee prior to initiation of the study. All experiments
were performed in accordance with guidelines and regulations set forth in Directive 2010/63/EU EEC.
Animal experiments were conducted at an accredited animal care facility (code: ES462500001091).
4.2. Experimental Design
Figure 2 illustrates the experimental design, conceived to elucidate the effects of transferring either
fresh or vitrified-warmed embryos on their preimplantation development and metabolism. NC embryos
were used as control reference. With this aim, a total of 12 donor females were induced to superovulate
using 3 µg of corifollitropin alpha [51]. After 3 days, females were inseminated with a semen pool
from unrelated males with proven fertility, ovulation being induced by an intramuscular injection of
1 µg of buserelin acetate (Hoechst Marion Roussel, Madrid, Spain). Three days post-insemination,
a total of 263 embryos catalogued as normal (presenting homogenous cellular mass and spherical
mucin coat and zona pellucida) were recovered post-mortem from 7 females. All embryos were
pooled for later distribution in the different parts of the study, thus reducing the effect of embryo
donors. Of the total, 150 embryos were subjected to vitrification, keeping 148 undamaged embryos
(presenting homogenous cellular mass, mucin coat, and spherical zona pellucida) after warming.
Then, 148 warmed and 113 fresh embryos were oviductally transferred into 7 foster mothers (35–40
embryos per foster mother). After 3 days (day 6 of embryonic development), 93 vitrified-transferred
(VT group) and 88 fresh-transferred (FT group) preimplantation embryos were recovered. In addition,
from the remaining 5 inseminated females, 176 coetaneous 6-day preimplantation embryos were
obtained without embryo manipulation (naturally-conceived group; NC). The survival rate (recovered
embryos/transferred embryos) was noted, and digital images were obtained to perform a morphometric
study. Finally, 8 pools of 10 in vivo developed preimplantation embryos were generated for each
experimental group (NC, FT, and VT), which were used to perform a comparative metabolomics study.
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Figure 2. Experimental design. First of all, day-5 fresh and vitrified embryos were compared after 48 h
of in vitro development under standard conditions. Their developmental potential and morphometric
features were assessed. Moreover, day-6 preimplantation embryos obtained after fresh and vitrified
embryo transfer were compared using naturally conceived embryos as reference. In this case, their
recovery rates, morphometric features, and metabolomics profiles were analysed.
4.3. Embryo Vitrification
Vitrification was achieved in two steps, following the protocol adapted from previous
studies [52–54]. Briefly, in the first step, embryos were placed for 2 min in a solution consisting
of 10% (v/v) dimethyl sulfoxide (DMSO) and 10% (v/v) ethylene glycol (EG) in base medium. Base
medium (BM) consisted of Dulbecco’s phosphate buffered saline supplemented with 0.2% (w/v) of
bovine serum albumin. In the second step, embryos were suspended for 1 min in a solution of 20%
DMSO and 20% EG in BM. Then, embryos were loaded into Cryotop®devices (8 embryos per device),
the surrounding vitrification solution was removed, and devices were rapidly plunged into liquid
nitrogen to achieve vitrification. For warming, embryos were placed in 2 mL of 0.33 M sucrose in BM
at 25 ◦C to remove cryoprotectants, and washed 5 min later with BM.
4.4. Embryo Transfer
Warmed or fresh embryos were laparoscopically transferred into the oviduct of foster mothers,
following the protocol described by Besenfelder and Brem [55]. Briefly, foster mothers were
anaesthetised with xylazine (5 mg/kg; Rompun; Bayern AG, Leverkusen, Germany) intramuscularly
and ketamine hydrochloride (35 mg/kg; Imalgene 1000; Merial S.A.S., Lyon, France) intravenously,
and placed in Trendelenburg’s position. Then, embryos were loaded in a 17G epidural catheter,
which was inserted through a 17G epidural needle into the inguinal region. Finally, while the
process was monitored by single-port laparoscopy, the catheter was introduced into the oviduct
through the infundibulum to release the embryos. Using this procedure, between 35 and 40 embryos
were transferred to each pseudopregnant foster mother induced to ovulate 68–72 h before transfer.
Both embryo vitrification and transfer processes used in this experiment were described in detail in
Garcia-Dominguez et al. [54].
4.5. In Vivo Embryo Development
A total of 261 embryos (148 vitrified-warmed and 113 fresh) were transferred into 7 foster mothers
and in vivo cultured during 72 h. Then, foster mothers and 5 pregnant females were euthanised,
and day-6 embryos were recovered by perfusion of each uterine horn with 10 mL of pre-warmed
BM. The survival rate was noted taking into account the number of embryos transferred and those
recovered. In the case of the NC group, the number of available embryos was estimated from the
number of corpora lutea (ovulation rate) in the ovaries, as has been used before [26].
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4.6. Morphometric Analysis
In vivo developed embryos were subjected to a morphometric analysis to compare the embryo
size between the experimental groups (VT vs. FT vs. NC). All embryos were photographed
and measured (diameter, perimeter, and area) in digital images using ImageJ analysis software
(http://rsb.info.nih.gov/ij/).
4.7. Semi-Polar and Non-Polar Metabolome Analysis
In vivo developed embryos were subjected to a comparative metabolomics analysis. For each
experimental group, 8 independent biological replicates, consisting of 10 embryos each, were analysed.
Then, 12 pools (4 VT, 4 FT and 4 NC) were used to study the semi-polar fraction, and 12 pools (4 VT, 4 FT
and 4 NC) were used to study the non-polar one. For each biological replicate, at least one technical
replicate was carried out. Targeted and untargeted liquid chromatography-electrospray ionisation-high
resolution mass spectrometry (LC-ESI-HRMS) analysis of the semi-polar metabolome were performed
as previously described [56–58], while targeted and untargeted liquid chromatography-atmospheric
pressure chemical ionisation-high resolution mass spectrometry (LC-APCI-HRMS) analyses of the
non-polar metabolome were carried out as reported previously [59–61]. Untargeted metabolomics
was performed using the SIEVE software (Thermo Fisher scientific). Principal components analysis
biplot (PCA-biplot) of untargeted metabolomes were created with BioVinci software (BioTuring Inc.,
San Diego, CA, USA). Targeted metabolite identification was performed by comparing chromatographic
and spectral properties with authentic standards (if available) and reference spectra, in-house database,
literature data, and on the basis of the m/z accurate masses, as reported in the PubChem database
(http://pubchem.ncbi.nlm.nih.gov/) for monoisotopic mass identification, or on the Metabolomics Fiehn
Lab Mass Spectrometry Adduct Calculator (http://fiehnlab.ucdavis.edu/staff/kind/Metabolomics/MS-
Adduct-Calculator/) in the case of adduction detection. Finally, DAMs were achieved as described
above. Metabolites were quantified in a relative way by normalisation on the internal standard
(formononetin and DL-α-tocopherol acetate) amounts.
4.8. Statistical Analysis
4.8.1. Survival Rate and Embryo Morphology Statistical Analysis
Differences in the survival rate and embryo diameter, perimeter, and area were assessed applying
a general linear model described above:
Yij = µ + Pi + COj + eij
where Yij was the trait to analyse, µ was the general mean, Pi was the fixed effect of experimental
groups (VT, FT, and NC), COj was the random effect of foster mother and eij was the error term of the
model. The random effect donor mother (COj). Survival rate was evaluated using a function probit link
with binomial error distribution. A p-value < 0.05 was considered indicative of a statistically significant
difference. The data are presented as mean ± standard error. Statistical analyses were performed with
the SPSS 21.0 software package (SPSS Inc., Chicago, IL, USA).
4.8.2. Metabolome Statistical Analysis
After chromatogram alignment and retrieval of all of the detected frames (e.g., ions), differentially
accumulated metabolites (DAMs) were validated by a statistical analysis (one-way ANOVA plus Tukey’s
pairwise comparison) using the SPSS software (SPSS Inc., Chicago, IL, USA). Benjamini–Hochberg
false discovery rate (FDR) was performed to correct for multiple testing (p > 0.05) [62].
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5. Limitations
The number of included samples is relatively small, which may restrict the interpretation of
our results. Thus, low sample size negatively affects the likelihood that a nominally statistically
significant finding reflects a true effect. Our results are based on p-value without correct for multiple
comparisons. The p-values have been listed for every comparison. Further study needs to validate our
results in a larger study sample. No other embryo develop time-points were examined. Therefore,
temporal changes in metabolites profiles during embryogenesis remain elusive. The choice to analyse
preimplantation rabbit embryos was based on our previous findings [19]. Consequently, the potential
involvement of ex vivo manipulation during assisted reproduction technologies of our animal model
remains to be determined. This model is characterised by the long-term and transgenerational
phenotypic, transcriptional, and metabolic effects in rabbit [63].
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/21/19/7116/
s1. Supplementary Table S1. Targeted identification of differentially accumulated metabolites in day-6 embryos
after in vivo development by natural conception (NC) or following fresh (FT) or vitrified (VT) embryo transfer.
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